Annual Total Long Term Liabilities
$686.00 K
-$3.51 M-83.64%
31 December 2023
Summary:
Enlivex Therapeutics annual total long term liabilities is currently $686.00 thousand, with the most recent change of -$3.51 million (-83.64%) on 31 December 2023. During the last 3 years, it has risen by +$187.00 thousand (+37.47%). ENLV annual total long term liabilities is now -87.27% below its all-time high of $5.39 million, reached on 31 December 2021.ENLV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$499.00 K
-$88.00 K-14.99%
30 June 2024
Summary:
Enlivex Therapeutics quarterly total long term liabilities is currently $499.00 thousand, with the most recent change of -$88.00 thousand (-14.99%) on 30 June 2024. Over the past year, it has dropped by -$3.32 million (-86.93%). ENLV quarterly long term liabilities is now -90.74% below its all-time high of $5.39 million, reached on 31 December 2021.ENLV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.6% | -86.9% |
| 3 y3 years | +37.5% | -90.7% |
| 5 y5 years | +246.5% | -43.5% |
ENLV Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.3% | +37.5% | -90.7% | at low |
| 5 y | 5 years | -87.3% | +246.5% | -90.7% | +111.4% |
| alltime | all time | -87.3% | -90.7% |
Enlivex Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $499.00 K(-15.0%) |
| Mar 2024 | - | $587.00 K(-14.4%) |
| Dec 2023 | $686.00 K(-83.6%) | $686.00 K(-82.0%) |
| Sept 2023 | - | $3.82 M(+3.1%) |
| June 2023 | - | $3.70 M(-7.3%) |
| Mar 2023 | - | $4.00 M(-4.7%) |
| Dec 2022 | $4.19 M(-22.2%) | $4.19 M(-9.0%) |
| Sept 2022 | - | $4.61 M(-0.7%) |
| June 2022 | - | $4.64 M(-11.2%) |
| Mar 2022 | - | $5.23 M(-3.0%) |
| Dec 2021 | $5.39 M(+980.0%) | $5.39 M(+0.7%) |
| Sept 2021 | - | $5.35 M(+1221.5%) |
| June 2021 | - | $405.00 K(-9.8%) |
| Mar 2021 | - | $449.00 K(-10.0%) |
| Dec 2020 | $499.00 K(+67.4%) | $499.00 K(0.0%) |
| Sept 2020 | - | $499.00 K(+111.4%) |
| June 2020 | - | $236.00 K(-7.8%) |
| Mar 2020 | - | $256.00 K(-14.1%) |
| Dec 2019 | $298.00 K | $298.00 K(-66.3%) |
| Sept 2019 | - | $884.00 K(+228.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $269.00 K(-70.0%) |
| Mar 2019 | - | $898.00 K(+353.5%) |
| Dec 2018 | $198.00 K(>+9900.0%) | $198.00 K(>+9900.0%) |
| June 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $125.00 K(+78.6%) |
| Dec 2015 | $70.00 K(>+9900.0%) | $70.00 K(+37.3%) |
| Sept 2015 | - | $51.00 K(+59.4%) |
| June 2015 | - | $32.00 K(+146.2%) |
| Mar 2015 | - | $13.00 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00 | - |
FAQ
- What is Enlivex Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual total long term liabilities year-on-year change?
- What is Enlivex Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly long term liabilities year-on-year change?
What is Enlivex Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ENLV is $686.00 K
What is the all time high annual total long term liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total long term liabilities is $5.39 M
What is Enlivex Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ENLV annual total long term liabilities has changed by -$3.51 M (-83.64%)
What is Enlivex Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ENLV is $499.00 K
What is the all time high quarterly long term liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total long term liabilities is $5.39 M
What is Enlivex Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ENLV quarterly total long term liabilities has changed by -$3.32 M (-86.93%)